
Conference: Asembia AXS25 Summit
Date: April 27 – May 1
Location: Las Vegas, Nevada
Booth: #1523
Meet us there
Stop by Booth #1523 to speak with members of our team about your upcoming projects and any Patient Services program needs.
Transform your drug development journey with Certara’s comprehensive solutions. From molecule to market, we seamlessly integrate science, technology, strategic and regulatory expertise to solve your unique challenges.
Discover moreUnify insights to accelerate drug development and achieve development milestones. Partner with Certara to unlock your pipeline’s potential.
Learn moreCertara’s software solutions offer transformative approaches across all drug development phases, aligning with recognized industry standards. By integrating advanced modeling, analytics, and automation, they break down silos, streamline workflows, and drive regulatory success.
View allTransform drug development with our tailored services. From predictive modeling to market access strategies, Certara’s integrated services enhance decision-making, streamline processes, and make your drug a safer bet.
View allCertara tailors solutions for biotech, pharma, and CROs, addressing unique challenges to drive success.
Learn who we work withCertara collaborates with leading biotech, pharma, and CRO partners to tackle complex challenges, deliver innovation, and shape the future of healthcare.
Learn moreWith over 1,000 articles spanning categories and solutions, Certara’s resources is a geek haven. It’s all here—built for scientists who dare to think different.
View allWith over 1,550+ employees in more than 30 countries, over 28% of which have PhDs, our vision is to transform drug development for good.
Learn more about usJoin a global leader transforming the future of drug development. Explore opportunities to innovate, grow, and make a difference in transforming lives.
Visit careers siteHome / Conference / Asembia AXS25 Summit
Conference: Asembia AXS25 Summit
Date: April 27 – May 1
Location: Las Vegas, Nevada
Booth: #1523
Characterized by high costs, more severe side effect profiles, and complex treatment regimens, specialty drugs have long since eclipsed traditional medications in driving biopharma market growth. In 2023, specialty therapies accounted for over 80% of the 55 novel drugs approved by the U.S. FDA. A constellation of patient services and vendors materialized in response to this shift, as biopharma companies worked to ensure patients could overcome a variety of barriers to initiating and adhering to therapy.
Today, the challenge is implementing a patient services program that aligns with patient needs, and is well received by health care providers and other stakeholers. Programs must accurately map to friction points in the patient journey, help differentiate your patient experience in the market and provide a return on your investment.
Patient Services Strategy is the latest offering available as part of Certara’s integrated approach to market access, pricing and reimbursement.
Stop by Booth #1523 to speak with members of our team about your upcoming projects and any Patient Services program needs.
Stop by Booth #1523 to speak with members of our team about your upcoming projects and any Patient Services program needs.
Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.
© 2025 Certara. All Rights Reserved. | Privacy policy